|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Available-for-sale (“AFS”) securities, at fair value (amortized cost of $8,586 and $8,770 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Held-to-maturity (“HTM”) securities, at amortized cost (fair value of $1,572 and $1,578 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||||
| Loans held-for-portfolio | ||||||||||||||||||||
| Allowance for credit losses (“ACL”) on loans | ||||||||||||||||||||
| Total loans held-for-portfolio, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank-owned life insurance (“BOLI”), net | ||||||||||||||||||||
| Other real estate owned (“OREO”) and repossessed assets, net | ||||||||||||||||||||
| Mortgage servicing rights (“MSRs”), at fair value | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") stock, at cost | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Lease right of use assets, net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Advance payments from borrowers for taxes and insurance | ||||||||||||||||||||
| Subordinated notes, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| COMMITMENTS AND CONTINGENCIES (NOTE 7) | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 10,000,000 shares authorized, none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 40,000,000 shares authorized, 2,568,043 and 2,567,953 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
